🔬 Interested in alternative production systems for #biopharmaceuticals? A recent study in #Scientific Reports showcases a #plantbased vaccine antigen effective against a bovine parasitic nematode (Ostertagia ostertagi), a significant concern for animal health globally.
🌱 The key innovation lies in #mimicking the native protein’s N-glycosylation pattern using Nicotiana benthamiana plants, achieving a 39% reduction in parasite egg output! This is a promising result comparable to the native antigen. This novel approach offers new possibilities for controlling parasitic nematodes, while transforming vaccine development in veterinary. Check out the full study for more insights (https://lnkd.in/gJSyap5C).
💡 At Hudson River Biotechnology, we specialize in developing in a few months #CRISPR-edited N. benthamiana plants without plant-specific glycosylation, making them ideal for producing your biopharmaceuticals. If you’re interested in exploring collaborative opportunities, please don’t hesitate to contact us at HRB for more information.